Evidence map›Paper›PMID 36869039›Full record

ArticleNPJ Regenerative medicine2023

Return of the Tbx5; lineage-tracing reveals ventricular cardiomyocyte-like precursors in the injured adult mammalian heart.

Panagiota Siatra, Giannis Vatsellas, Athanasia Chatzianastasiou, Evangelos Balafas, Theodora Manolakou, Andreas Papapetropoulos, Anna Agapaki, Eleni-Taxiarchia Mouchtouri, Prashant J Ruchaya, Artemis G Korovesi and 4 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Panagiota SiatraCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Giannis VatsellasCenter for Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Athanasia ChatzianastasiouDepartment of Pharmacy, Laboratory of Pharmacology, National and Kapodistrian University of Athens, Athens, Greece.
Evangelos BalafasCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Theodora ManolakouCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID http://orcid.org/0000-0001-5284-6655
Andreas PapapetropoulosCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID http://orcid.org/0000-0002-4253-5930
Anna AgapakiHistochemistry Facility, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Eleni-Taxiarchia MouchtouriCenter for Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Prashant J RuchayaSchool of Health, Sport and Biosciences, University of East London, London, UK.
Artemis G KorovesiCenter for Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.ORCID http://orcid.org/0000-0003-1410-6757
Manolis MavroidisCenter for Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Dimitrios ThanosCenter for Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Dimitris BeisCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Ioannis KokkinopoulosCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece. ikokkinopoulos@bioacademy.gr.ORCID http://orcid.org/0000-0002-8143-6695
Academy of Athens · GRBiomedical Research Foundation of the Academy of Athens · GRNational and Kapodistrian University of Athens · GRUniversity of East London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The single curative measure for heart failure patients is a heart transplantation, which is limited due to a shortage of donors, the need for immunosuppression and economic costs. Therefore, there is an urgent unmet need for identifying cell populations capable of cardiac regeneration that we will be able to trace and monitor. Injury to the adult mammalian cardiac muscle, often leads to a heart attack through the irreversible loss of a large number of cardiomyocytes, due to an idle regenerative capability. Recent reports in zebrafish indicate that Tbx5a is a vital transcription factor for cardiomyocyte regeneration. Preclinical data underscore the cardioprotective role of Tbx5 upon heart failure. Data from our earlier murine developmental studies have identified a prominent unipotent Tbx5-expressing embryonic cardiac precursor cell population able to form cardiomyocytes, in vivo, in vitro and ex vivo. Using a developmental approach to an adult heart injury model and by employing a lineage-tracing mouse model as well as the use of single-cell RNA-seq technology, we identify a Tbx5-expressing ventricular cardiomyocyte-like precursor population, in the injured adult mammalian heart. The transcriptional profile of that precursor cell population is closer to that of neonatal than embryonic cardiomyocyte precursors. Tbx5, a cardinal cardiac development transcription factor, lies in the center of a ventricular adult precursor cell population, which seems to be affected by neurohormonal spatiotemporal cues. The identification of a Tbx5-specific cardiomyocyte precursor-like cell population, which is capable of dedifferentiating and potentially deploying a cardiomyocyte regenerative program, provides a clear target cell population for translationally-relevant heart interventional studies.

Identifiers

PMID36869039
PMCPMC9984483
OpenAlexW4323048857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.